MDRX · As filed with the SEC
Veradigm cash flow statement, by quarter
The statement as Veradigm presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | Q4 2024 3 months ended Dec 31, 2024 | Q4 2022 3 months ended Dec 31, 2022 | Q3 2022† 3 months ended Sep 30, 2022 | Q2 2022† 3 months ended Jun 30, 2022 | Q1 2022 3 months ended Mar 31, 2022 | Q4 2021† 3 months ended Dec 31, 2021 | Q3 2021† 3 months ended Sep 30, 2021 | Q2 2021† 3 months ended Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net income (loss) | — | — | — | — | 22,857,000 | — | — | — |
| Less: Income (loss) from discontinued operations | — | — | — | — | 4,386,000 | — | — | — |
| Income (loss) from continuing operations, net of tax | — | — | — | — | 18,471,000 | — | — | — |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||||
| Depreciation and amortization | — | — | — | — | 14,101,000 | — | — | — |
| Non-cash lease expense, net | — | — | — | — | (3,223,000) | — | — | — |
| Stock-based compensation expense | — | — | — | — | 6,324,000 | — | — | — |
| Deferred taxes | — | — | — | — | (17,042,000) | — | — | — |
| Equity in net loss of unconsolidated investments | — | — | — | — | 398,000 | — | — | — |
| Other (income) expense, net | — | — | — | — | 226,000 | — | — | — |
| Changes in operating assets and liabilities (net of businesses acquired): | ||||||||
| Accounts receivable and contract assets, net | — | — | — | — | 26,205,000 | — | — | — |
| Prepaid expenses and other assets | — | — | — | — | 5,431,000 | — | — | — |
| Accounts payable | — | — | — | — | 10,210,000 | — | — | — |
| Accrued expenses | — | — | — | — | 13,031,000 | — | — | — |
| Accrued compensation and benefits | — | — | — | — | (13,291,000) | — | — | — |
| Deferred revenue | — | — | — | — | (28,352,000) | — | — | — |
| Other liabilities | — | — | — | — | 2,022,000 | — | — | — |
| Net cash provided by (used in) operating activities - continuing operations | — | — | — | — | 34,511,000 | — | — | — |
| Net cash provided by (used in) operating activities - discontinued operations | — | — | — | — | 34,750,000 | — | — | — |
| Net cash provided by (used in) operating activities | — | — | — | — | 69,261,000 | — | — | — |
| Cash flows from investing activities: | ||||||||
| Capital expenditures | — | — | — | — | (345,000) | — | — | — |
| Capitalized software | — | — | — | — | (9,600,000) | — | — | — |
| Cash paid for business acquisitions, net of cash acquired | — | — | — | — | (24,106,000) | — | — | — |
| Sale of businesses, net of cash divested | — | — | — | — | 1,083,000 | — | — | — |
| Purchases of equity securities, other investments and related intangible assets, net | — | — | — | — | 0 | — | — | — |
| Net cash provided by (used in) investing activities - continuing operations | — | — | — | — | (32,968,000) | — | — | — |
| Net cash provided by (used in) investing activities - discontinued operations | — | — | — | — | (11,231,000) | — | — | — |
| Net cash provided by (used in) investing activities | — | — | — | — | (44,199,000) | — | — | — |
| Cash flows from financing activities: | ||||||||
| Taxes paid related to net share settlement of equity awards | — | — | — | — | (13,275,000) | — | — | — |
| Credit facility payments | — | — | 0† | (175,000,000)† | (25,000,000) | (25,000,000)† | (50,000,000)† | 0† |
| Credit facility borrowings, net of issuance costs | — | — | — | — | 25,000,000 | — | — | — |
| Repurchase of common stock | — | — | — | — | (49,679,000) | — | — | — |
| Intercompany to/from parent/subsidiaries | — | — | — | — | 11,685,000 | — | — | — |
| Payment of acquisition and other financing obligations | — | — | — | — | 0 | — | — | — |
| Net cash provided by (used in) financing activities - continuing operations | — | — | — | — | (51,269,000) | — | — | — |
| Net cash provided by (used in) financing activities - discontinued operations | — | — | — | — | (11,697,000) | — | — | — |
| Net cash provided by (used in) financing activities | — | — | — | — | (62,966,000) | — | — | — |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | — | (11,000) | — | — | — |
| Net increase (decrease) in cash and cash equivalents | — | — | — | — | (37,915,000) | — | — | — |
| Cash, cash equivalents and restricted cash, beginning of period | 447,900,000 | 501,904,000 | 521,471,000 | 152,605,000 | 190,520,000 | 216,320,000 | 231,383,000 | 515,510,000 |
| Cash, cash equivalents and restricted cash, end of period | 294,253,000 | 447,900,000 | 501,904,000 | 521,471,000 | 152,605,000 | 190,520,000 | 216,320,000 | 231,383,000 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.